Live Breaking News & Updates on Seiji Wakao

Stay updated with breaking news from Seiji wakao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sumitomo Pharma : May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 transcript

Sumitomo Pharma Co., Ltd.

Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024

May 1, 2024

. ....

United States , Hiroshi Wada , Morgan Stanley , Fumiyoshi Sakai , Astella Mirabegron , Seiji Wakao , Shinichiro Muraoka , Kazuaki Hashiguchi , Stephen Barker , Toru Kimura , Hidemaru Yamaguchi , Naoki Noguchi , Hiroshi Nomura , Tokyo Head Office , Sumitomo Pharma Co Ltd , Sumitomo Pharma Co , Corporate Communications Vice , Head Of Corporate Communications , Financial Forecasts Revision , Financial Forecasts , Senior Managing , Officer Corporate Governance , Communications Vice President , Corporate Communications , Securities Japan , Sumitomo Pharma ,

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript

Christopher O Reilly: Thank you very much for joining us out of your busy schedule today for the earnings call for Second Quarter Fiscal 2023 with Takeda Pharmaceutical Company Limited. ....

United States , Christophe Weber , Christopher Oreilly , Hidemaru Yamaguchi , Citi Yamaguchi San , Ramona Sequeira , Seiji Wakao , Shinichiro Muraoka , Julie Kim , Takeda Pharmaceutical Company , Takeda Pharmaceutical Co Ltd , Morgan Stanley , Unidentified Company Representative , American College Of Rheumatology , Global Portfolio Division , Takeda Pharmaceutical Company Limited , World Health Organization Advisory Group , Call Transcript October , Second Quarter Fiscal , Private Securities Litigation Reform Act , Andy Plump , Chief Financial Officer , Costa Saroukos , American College , World Health Organization , Advisory Group ,

Daiichi Sankyo Company, Limited (DSKYF) Q2 2022 Earnings Call Transcript

Daiichi Sankyo Company, Limited (OTCPK:DSKYF) Q2 2022 Results Conference Call October 31, 2022 01:30 AM ET Company Participants Sunao Manabe - Representative Director, President and CEO. ....

United States , Hong Kong , San Antonio , South Korea , Naomi Kumagai , Seiji Wakao , Hidemaru Yamaguchi , Daiichi Sankyo , Wataru Takasaki , Bristol Myers Squibb , Fumiyoshi Sakai , Sunao Manabe , Kazuaki Hashiguchi , Shinichiro Muraoka , Hiroyuki Okuzawa , Pharma Company Of The Year , Morgan Stanley , Rd Division , Company Participants , Daiichi Sankyo Company , Credit Suisse , District Court , Us Federal District Court , Mitsubishi Ufj , Unidentified Company Representative , Rd Division Head ,

Daiichi Sankyo Company, Limited (DSKYF) Q1 2022 Results - Earnings Call Transcript

Daiichi Sankyo Company, Limited (OTCPK:DSKYF) Q1 2022 Earnings Conference Call July 29, 2022 2:00 AM ETCompany ParticipantsHiroyuki Okuzawa - Head, Corporate Planning and Management. ....

United States , Hong Kong , Morgan Stanley , Naomi Kumagai , Seiji Wakao , Hidemaru Yamaguchi , Daiichi Sankyo , Wataru Takasaki , Daiichi Sankyo Espha , Fumiyoshi Sakai , Kazuaki Hashiguchi , Shinichiro Muraoka , Tasuku Honjo , Hiroyuki Okuzawa , Rd Division , Company Participants , Daiichi Sankyo Company , Us District Court , Bioindustry Association Of Japan , Roche Group , Rd Division Head , Mitsubishi Ufj , Management Division , Conference Call July , Corporate Planning , Financial Results Presentation ,

Eisai Co., Ltd. (ESALF) CEO Haruo Naito on Q4 2022 Results - Earnings Call Transcript

Eisai Co., Ltd. (OTCPK:ESALF) Q4 2022 Earnings Conference Call May 13, 2022 3:30 AM ET Company Participants Haruo Naito - CEO Ivan Cheung - Senior VP & President of Neurology Business. ....

United States , Seiji Wakao , Haruo Naito , Hidemaru Yamaguchi , Motoya Kohtani , Ivan Cheung , Ryohei Yanagi , Asia Pacific , Teruyuki Masaka , Company Participants , Oncology Business Group President , Medicare Medicaid Services , Oncology Business Group , Eisai Company , Eisai Co Ltd , Neurology Business Group , National Reimbursement Drug List , Conference Call May , Chief Discovery Officer , Representative Executive Officer , Medicaid Services , Lable Extension , North America , Lenvima Mono , Citigroup Securities , Neurology Business Group President ,